CervoMed Inc. — Investor Relations & Filings
Filings indexed
950
across all filing types
Latest filing
2026-05-18
Regulatory Filings
Country
US
United States of America
Listing
US
CRVO
CervoMed Inc. is a clinical-stage biotechnology company that develops treatments for age-related neurologic disorders. The company focuses on neurodegenerative diseases, including Dementia with Lewy Bodies (DLB), Alzheimer's, and Huntington's disease. Its lead investigational candidate is neflamapimod, an orally administered, small molecule brain penetrant that inhibits the p38 alpha protein kinase. CervoMed's scientific approach is based on early intervention to reverse synaptic dysfunction, which is considered a reversible aspect of the neurodegenerative process, before the onset of irreversible nerve cell death. The company is advancing neflamapimod through clinical trials, including a Phase 2 study for patients with DLB.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 8-K | 2026-05-18 | English | |
| FORM 10-Q | 2026-05-15 | English | |
| 8-K - CervoMed Inc. (0001053691) (Filer) | 2026-04-22 | English | |
| 8-K - CervoMed Inc. (0001053691) (Filer) | 2026-03-19 | English | |
| 8-K - CervoMed Inc. (0001053691) (Filer) | 2026-03-17 | English | |
| 8-K - CERVOMED INC. (0001053691) (Filer) | 2026-02-18 | English |
Browse filings by year
24 years- 2026 13 filings
- 2025 60 filings
- 2024 75 filings
- 2023 79 filings
- 2022 67 filings
- 2021 46 filings
- 2020 71 filings
- 2019 64 filings
- 2018 44 filings
- 2017 52 filings
- 2016 70 filings
- 2015 28 filings
- 2014 70 filings
- 2013 32 filings
- 2012 22 filings
- 2011 28 filings
- 2010 18 filings
- 2009 28 filings
- 2008 25 filings
- 2007 5 filings
- 2001 2 filings
- 2000 32 filings
- 1999 12 filings
- 1998 7 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
13 filings
| |||||
| 46468838 | FORM 8-K | 2026-05-18 | English | ||
| 46355067 | FORM 10-Q | 2026-05-15 | English | ||
| 35397934 | 8-K - CervoMed Inc. (0001053691) (Filer) | 2026-04-22 | English | ||
| 32989537 | 8-K - CervoMed Inc. (0001053691) (Filer) | 2026-03-19 | English | ||
| 32967541 | 8-K - CervoMed Inc. (0001053691) (Filer) | 2026-03-17 | English | ||
| 32886393 | 8-K - CERVOMED INC. (0001053691) (Filer) | 2026-02-18 | English | ||
| 32886390 | 4 - CERVOMED INC. (0001053691) (Filer) | 2026-02-13 | English | ||
| 32886388 | 4 - CERVOMED INC. (0001053691) (Filer) | 2026-02-13 | English | ||
| 32886389 | 4 - CERVOMED INC. (0001053691) (Filer) | 2026-02-13 | English | ||
| 32886391 | 4 - CERVOMED INC. (0001053691) (Filer) | 2026-02-13 | English | ||
| 32886392 | 4 - CERVOMED INC. (0001053691) (Filer) | 2026-02-13 | English | ||
| 26854078 | 4 Filing | 2026-02-13 | English | ||
| 26854052 | 8-K Filing | 2026-01-08 | English | ||
|
2025
2 filings
| |||||
| 10998162 | FORM 4 | 2025-12-05 | English | ||
| 10998163 | FORM 3 | 2025-12-05 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AIM ImmunoTech Inc.
Immuno-pharma company developing therapeutics for oncology,…
|
AIM | US | Professional, scientific and te… |
|
Ainos, Inc.
Develops AI-driven diagnostics, immune therapeutics, and te…
|
AIMD | US | Professional, scientific and te… |
|
Akela Pharma Inc.
Integrated drug developer focused on pain and inhalation, p…
|
— | CA | Professional, scientific and te… |
|
Akero Therapeutics, Inc.
Clinical-stage company developing treatments for serious me…
|
AKRO | US | Professional, scientific and te… |
|
Aladdin Healthcare Technologies SE
Develops AI-powered tools for drug discovery and diagnostic…
|
NMI | DE | Professional, scientific and te… |
|
Alamar Biosciences, Inc.
Powering precision proteomics for earliest disease detectio…
|
ALMR | US | Professional, scientific and te… |
|
Alaunos Therapeutics, Inc.
Clinical-stage immuno-oncology company developing TCR-T cel…
|
TCRT | US | Professional, scientific and te… |
|
ALGORAE PHARMACEUTICALS LIMITED
Biopharmaceutical firm using AI to develop neurodegenerativ…
|
1AI | AU | Professional, scientific and te… |
|
Aligos Therapeutics, Inc.
A clinical-stage biopharmaceutical company developing thera…
|
ALGS | US | Professional, scientific and te… |
|
Allelix Biopharmaceuticals Inc.
Biopharmaceutical R&D focused on protein-based drugs and ne…
|
ALX | CA | Professional, scientific and te… |
CervoMed Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34364/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34364 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34364 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34364 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34364}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CervoMed Inc. (id: 34364)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.